Society for Translational Oncology (STO) Currently Accepting Applications for the 2018 STO Fellows Forum

Wednesday, July 18, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

The Society for Translational Oncology (STO) is currently accepting applications for the 2018 STO Fellows Forum (STOFF), to be held at the Lansdowne Hotel, Leesburg, Virginia, October 11-14, 2018.

DURHAM, N.C., July 18, 2018 /PRNewswire-PRWeb/ -- The Society for Translational Oncology (STO) is currently accepting

applications for the 2018 STO Fellows Forum (STOFF), to be held at the Lansdowne Hotel, Leesburg, Virginia, October 11-14, 2018. This intensive, three-day workshop provides 25 young oncologists with the opportunity to develop their skills in translational cancer research, explore the science of drug development in oncology, and network with peers and prominent faculty mentors. The deadline for applying is July 31, 2018.

Each year, STOFF brings together a faculty of prominent scientists, clinicians, ethicists, industry representatives, and biotech investors to act as mentors to oncology fellows and junior faculty with an interest in translational research. Fellows are drawn from leading medical, surgical, radiation, and pediatric oncology groups as well as surgical subspecialty fellowships from the United States and abroad. Since its founding in 1996 by Bruce Chabner, MD, STOFF has provided unique mentoring and networking opportunities to over 400 early-career oncologists.

STOFF is led by co-chairs Dr. Keith Flaherty (Massachusetts General Hospital/Harvard Medical School), Dr. Stacey Berg (Baylor College of Medicine), and Dr. Ross Levine (Memorial Sloan Kettering Cancer Center). The interactive workshop-style STOFF experience will be enhanced in 2018 with dedicated office hours with these distinguished co-chairs, providing additional time for one-on-one mentoring.

STOFF has earned international acclaim for its focused, practical, and personal tutorials preparing oncologists to advance cancer drug development. Presentations cover topics ranging from drug target and biomarker validation, to design of translational clinical trials, to regulatory perspectives on oncology drug development. Participants are also tutored in guidelines for good basic research as well as the practices of successful grant-writing. Breakout sessions, Q&A periods, and a daily mentoring clinic provide ample opportunity for interaction between faculty and mentees.

Application materials can be found at: Tuition expenses, meeting materials, housing, and meals will be covered for fellow-level participants. Junior faculty (within 5 years of training completion) are also eligible to apply, but will be responsible for their own travel and accommodations.

Society for Translational Oncology: STO is a 501(c)3 nonprofit professional organization dedicated to the continuing education of oncology professionals and to improvement in the quality and safety of care for cancer patients. The Society is committed to:

  • Bringing knowledge and strategies for critical new developments in cancer treatment into the practice environment of the community oncologist;
  • Bridging the "translational gap" between discovery and delivery of care to the patient; and
  • Providing educational activities to improve physician competencies and strategies for screening, prevention, diagnosis, treatment, and management of patients with cancer.

Contact: Nicole Fortune nicole.fortune(at)sto-online(dot)org (919) 433-0489


SOURCE Society for Translational Oncology

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store